HIV testing in Europe
In 2015, ECDC commissioned an evaluation of a previous ECDC publication, HIV testing: increasing uptake and effectiveness in the European Union guidance. The aim of the evaluation was to understand the use and impact of the 2010 HIV testing guidance in the EU/EEA, and to make recommendations for future steps by ECDC in this area, including, potentially, an updated guidance.
HIV Evaluation Guidance - Annex 1
In 2010, ECDC published the guidance HIV testing: increasing uptake and effectiveness in the European Union. In consideration of the recent developments in this field, ECDC is considering to update the guidance in 2016.
HIV Evaluation Guidance - Annex 2
As preparatory work, an evaluation of the impact of the 2010 guidance in the EU/EEA at national and supra-national levels has been commissioned.
HIV Evaluation Guidance - Annex 3
Citation analysis for HIV testing: increasing uptake and effectiveness in the European Union
Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia Monitoring implementation of the Dublin Declaration – 2022 progress report
14 Feb 2023 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
HIV/AIDS surveillance in Europe 2022 (2021 data)
30 Nov 2022 - This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
Continuum of HIV care - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2021 progress report
30 Nov 2022 - By 2021, 48 of 55 countries in Europe and Central Asia provided data on at least one stage of the continuum of HIV care (compared to 40 countries in 2018). A total of 47 countries were able to provide data for at least two consecutive stages of the continuum (compared to 45 in 2020) and 40 countries provided data on all four stages.